Last checked at 4 Aug 2022 12:33
Proteome Sciences shares rise 10% after swing to interim profit
(Alliance News) - Proteome Sciences PLC on Thursday said it swung to an interim profit in the first half of 2022 on the strength of its TMT reagents.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Proteome Share News (PRM)
PRM Share
Price
PRM Share
News
PRM Share
Chat
PRM Share
Trades4
PRM
Live RNS
PRM Share
Charts
PRM Level 2
Console
PRM Live
Share Price
PRM Broker
Ratings
PRM Directors
Deals
PRM Financial
Diary
PRM
Fundamentals
PRM Short
Positions
PRM
Media
Proteome Information
Share Price Information for Proteome (PRM)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
4.16
Bid:
3.52
Ask:
4.80
Change:
0.16 (4.00%)
Spread:
1.28 (36.364%)
Open:
4.00
High:
0.00
Low:
0.00
Prev. Close:
4.16
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Proteome rockets on Alzheimer's blood test
Wed, 28th Mar 2012 10:46
Pharma group Proteome Sciences has had a strong morning on the markets after announcing success in its project to develop better diagnostic tools for Alzheimer's disease.A study of 1,000 patients has shown three distinct "biomarkers" in people's blood which can discriminate between mild "cognitive impairment" (a syndrome often preceding Alzheimer's), Alzheimer's itself and control groups who do not have the condition.Proteome Sciences is filing patents for the "panels" in the blood that contain the biomarkers.It is estimated that 60% of people with Alzheimer's disease have not been properly diagnosed and therefore are not being given the correct drugs and care. The capability to distinguish between different levels of the disease will enable drug developers to improve patient care and people with mild symptoms are likely to benefit the most from new disease-modifying drugs.The key is that Proteome may be able to develop a simple blood test to determine progression of Alzheimer's as opposed to the current diagnostic methods of invasive lumbar punctures or expensive MRI scans.Presenting the data at a conference in Melbourne, Australia, Professor Simon Lovestone, who has worked with Proteome for the National Institute for Health Research said: "As new treatments for Alzheimer's disease are being developed, there is an increasing need for accurate and accessible markers of disease severity and progression. We will move quickly to support the development of clinical tests based on these biomarker panels."Shares in Proteome had risen 8.85% by 11:08. BS
More News
3 Aug 2022 15:57
TRADING UPDATES: Ensilica expects annual profit ahead of expectations
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more3 Aug 2022 15:33
Proteome reaches milestone in launch of proteomics service
(Sharecast News) - Proteome Sciences has completed its next milestone towards the launch of 'single cell proteomics' services, it announced on Wednesday, dubbed 'SysQuant SCP'.
Read more16 May 2022 16:20
TRADING UPDATES: Proteome set for profit rise; Kromek expects loss
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more16 May 2022 13:35
Proteome Sciences maintains strong order book
(Sharecast News) - Proteome Sciences said in an update on Monday that it had maintained a strong order book after recording a small profit in 2021.
Read more12 May 2022 11:14
IN BRIEF: Proteome Sciences secures contract with US academic group
Proteome Sciences PLC - Drug development services provider - Secures a contract from major US academic group to evaluate changes on the proteome and phospho-proteome of tissue and blood samples taken from people with and without a neurodegenerative disease. The contract's value exceeds GBP500,000. Proteome refers to entire set of proteins in a cell or organism.
Read more12 May 2022 10:47
AIM WINNERS & LOSERS: Arc Minerals "turning point"; Titon posts loss
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read more22 Apr 2022 12:01
DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:
Read more31 Mar 2022 13:04
TRADING UPDATES: Impellam and Maintel in profit; Curtis Banks prospers
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more30 Mar 2022 19:23
IN BRIEF: Proteome Sciences amends GBP1 million loan with Vulpes
Proteome Sciences PLC - drug development services provider - Amends GBP1 million loan with Vulpes Investment Management Private Ltd, which was signed in the summer of 2018. Accrued interest now repayable on June 30, 2023, extended from May 1, 2022. Notes GBP700,000 is currently drawn on facility.
Read more29 Mar 2022 15:01
UK earnings, trading statements calendar - next 7 days
| Wednesday 30 March | |
| Anglo Pacific Group PLC | Full Year Results |
| Bank of Cyprus Holdings PLC | Full Year Results |
| Bowleven PLC | Half Year Results |
| Canadian Overseas Petroleum Ltd | Full Year Results |
| Ebiquity PLC | Full Year Results |
| Equals Group PLC | Full Year Results |
| Gulf Keystone Petroleum Ltd | Full Year Results |
| Inspired PLC | Full Year Results |
| Keywords Studios PLC | Full Year Results |
| Michelmersh Brick Holdings PLC | Full Year Results |
| Shepherd Neame Ltd | Half Year Results |
| Team17 Group PLC | Full Year Results |
| Thursday 31 March | |
| Eleco PLC | Full Year Results |
| BBGI Global Infrastrcture SA | Full Year Results |
| Chesnara PLC | Full Year Results |
| Gattaca PLC | Half Year Results |
| Hostelworld Group PLC | Full Year Results |
| James Halstead PLC | Half Year Results |
| Mears Group PLC | Full Year Results |
| Record PLC | Full Year Results |
| RTW Venture Fund Ltd | Full Year Results |
| S4 Capital PLC | Full Year Results |
| Sportech PLC | Full Year Results |
| Proteome Sciences PLC | Full Year Results |
| Provident Financial PLC | Full Year Results |
| Friday 1 April | |
| HydrogenOne Capital Growth PLC | Full Year Results |
| Renew Holdings PLC | Trading Statement |
| Medica Group PLC | Full Year Results |
| Monday 4 April | |
| CentralNic Group PLC | Full Year Results |
| Elixirr International PLC | Full Year Results |
| Xpediator PLC | Full Year Results |
| Tuesday 5 April | |
| DP Eurasia NV | Full Year Results |
| Homeserve PLC | Trading Statement |
| Moonpig Group PLC | Trading Statement |
| Next Fifteen Communications Group PLC | Full Year Results |
| Quixant PLC | Full Year Results |
| SourceBio International PLC | Full Year Results |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |
3 Feb 2022 22:31
TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise
TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise
Read more20 Dec 2021 11:41
AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal
AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal
Read more20 Dec 2021 10:45
Proteome Sciences shares climb on GBP1 million contract win
Proteome Sciences shares climb on GBP1 million contract win
Read more20 Dec 2021 10:08
Proteome Sciences secures $1m contract with pharmaceutical major
(Sharecast News) - Proteomics and biomarker research firm Proteome Sciences has secured a contract valued at more than £1.0m from an unnamed major pharmaceutical company.
Read more